ACTRN12619001722189
Terminated
Phase 4
Effect of an Olive Leaf Extract compared to a placebo on Cold and Flu Symptoms in an AdultPopulation – A double blind, randomised controlled trial
Pharmactive0 sites135 target enrollmentStarted: December 6, 2019Last updated:
Overview
- Phase
- Phase 4
- Status
- Terminated
- Sponsor
- Pharmactive
- Enrollment
- 135
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (—)
- Sex
- All
Inclusion Criteria
- •Male and females 18\-65 years old
- •Generally healthy \- Absence of chronic sickness (EPOC, metabolic stress related diseases)
- •Able to provide informed consent
Exclusion Criteria
- •Unstable or serious illness (e.g. kidney, liver, GIT, heart conditions, diabetes, thyroid gland function,
- •Malignancy, lung conditions or chronic asthma)\*
- •Acute sickness experienced in the past 2 months
- •Serious mood disorders or neurological disorders such as MS
- •Active smokers and/or nicotine or drug abuse
- •Chronic past and/or current alcohol use (\>14 alcoholic drinks week)
- •Allergic to any of the ingredients in active or placebo formula
- •Pregnant or lactating woman
- •People medically prescribed to take drugs that would affect the immune and/or the inflammatory
- •Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
Investigators
Similar Trials
Recruiting
Phase 1
Study of effect of olive leaves on diabetic neuropathyIRCT20100513003922N4Kermanshah University of Medical Sciences66
Recruiting
Not Applicable
Effects of a combination of olive leaf extract and potassium on blood pressure in subjects with mild to moderate hypertension - a doubleblind, randomized, placebocontrolled studyMild to moderately elevated blood pressure (high normal and hypertension grade 1)DRKS00031955APOMEDICA Pharmazeutische Produkte GmbH70
Completed
Not Applicable
The effect of olive leaf extract administration on cardiovascular healthRisicofactoren voor cardiovasculaire ziekten(borderline) hypercholesterolemiahigh cholesteroloverweightobesityNL-OMON44077niversiteit Maastricht80
Completed
Phase 2
Olive (Olea europaea) leaf extract on blood pressureEssential hypertension.Hypertensive diseasesIRCT2017043033730N1Vice Chancellor for research of Qazvin University of Medical Sciences60
Not yet recruiting
Phase 2
effect of olive leaf extract on Covid-19 patientsCOVID - 19.Coronavirus infection, unspecifiedB34.2IRCT20201128049520N1Khoram-Abad University of Medical Sciences129